The weekly litigation news digest is live. Subscribe now

IP Verse

Compounds For Use In The Treatment Of Erbb2+ Brain Cancer - EP3400943

The patent EP3400943 was granted to Array Biopharma on Dec 2, 2020. The application was filed on Mar 25, 2013 under application number EP18162971A. The patent is currently recorded with a legal status of "Revoked".

EP3400943

ARRAY BIOPHARMA
Application Number
EP18162971A
Filing Date
Mar 25, 2013
Status
Revoked
Feb 8, 2025
Publication Date
Dec 2, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
SANDOZSep 1, 2021TER MEER STEINMEISTER & PARTNERADMISSIBLE
TEVA PHARMACEUTICALSSep 1, 2021KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2007059257
OPPOSITIONWO2007059257
OPPOSITIONWO2013142875
SEARCHWO2007059257
SEARCHWO2009042618
SEARCHWO2013056108

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents